ADB CAPITAL MANAGEMENT
ADB Capital Management focuses on helping individuals identify financial goals and manage resources. The firm also provides quality retirement plan solutions to help organizations retain employees and provide better retirement outcomes.
ADB CAPITAL MANAGEMENT
Industry:
Finance Financial Services Wealth Management
Address:
Eugene, Oregon, United States
Country:
United States
Website Url:
http://www.adbcap.com
Total Employee:
1+
Status:
Active
Contact:
+1 541 302 5814
Email Addresses:
[email protected]
Similar Organizations
Brol Capital Management
Brol Capital Management works to provide wealth management advice.
Fountainhead Capital Management, Llc
Fountainhead Capital Management offers a new approach to wealth management.
Insight Investment Counsel
Insight Investment Counsel is a full service, independent wealth management firm.
Norrep Capital Management
Norrep Capital Management provides Canadians with an independent choice for their investments.
Parks Wealth Management
Parks Wealth Management is an independent wealth management firm in Ridgewood, New Jersey.
Pazera Capital Management
Pazera Capital Management, Inc. is an independent wealth management firm located in Houston and Rockport, Texas.
Quadravest Capital Management
Quadravest Capital Management Inc. is an independent investment management firm.
Spectrum Wealth Management
Spectrum Wealth Management is an independent boutique wealth management firm.
Verde Capital Management
Verde Capital Management is a money management and wealth management firm.
Waterloo Capital
Waterloo Capital is an independent wealth management firm.
Windham Capital Management
Windham Capital Management is an independent asset management firm.
More informations about "ADB Capital Management"
Advanced Accelerator Applications - Wikipedia
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases. In late October 2017, Reuters announced that Novartis would acquire the company for $3.9 billion…See details»
RLT Medical Information Contact Form | Advanced Accelerator …
Advanced Accelerator Applications a Novartis Company, with offices at 4, rue de la Tour de l’Ile, 1204 Geneva, Switzerland, and its Affiliates (hereinafter collectively referred to as "ADACAP") …See details»
Advanced Accelerator Applications - Crunchbase
Organization. Advanced Accelerator Applications . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. AAA is an …See details»
Advanced Accelerator Applications | LinkedIn
Advanced Accelerator Applications | 37,655 followers on LinkedIn. We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – …See details»
Radiopharmaceutical cancer treatment Lutathera® …
Oct 8, 2020 Lutathera is the first and only therapeutic radiopharmaceutical approved by Health Canada for the treatment of GEP-NETs; Lutathera directly targets tumours by binding to cancer cell receptorsSee details»
S. BUONO | CEO | Advanced Accelerator Applications …
Stefano Buono is an accomplished physicist and alumnus of The European Organization for Nuclear Research (CERN). For the past 15 years, Mr. Buono has served as Chief Executive Officer and board ...See details»
Career Search - Advanced Accelerator Applications
Job Title Sort ascending Business Location Site Date Posted; Feasibility Manager (m/w/d) Regulär (Außendienst), Full time Innovative Medicines: Germany : Bavaria (without …See details»
Advanced Accelerator Applications - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Advanced Accelerator Applications. Use the PitchBook Platform to explore the full profile.See details»
Advanced Accelerator Applications - ZoomInfo
Jan 11, 2024 Advanced Accelerator Applications contact info: Phone number: +33 450993070 Website: www.adacap.com What does Advanced Accelerator Applications do? Founded in …See details»
Novartis announces the planned acquisition of Advanced …
Oct 30, 2017 Novartis to acquire Advanced Accelerator Applications pending outcome of tender offer and works council consultation Acquisition would add Lutathera ® , a first-in-class …See details»
Novartis announces the planned acquisition of Advanced …
Basel, October 30, 2017 - Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to …See details»
Advanced Accelerator Applications Receives FDA Approval for
Basel, January 26, 2018 - Novartis AG (NYSE: NVS) today announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug …See details»
Neuromuscular/SMA Head International - Novartis
3 days ago The International Neuromuscular/SMA DA Head is accountable for end-to-end asset strategy in major International markets. The DA Head role will evolve the early asset strategy …See details»
Advanced Accelerator Applications to Build Targeted ... - BioSpace
Jun 30, 2020 Advanced Accelerator Applications S.A., a Novartis company, announced it has executed a sales and purchase agreement for land on which a 50,000 square foot targeted …See details»
Health Canada approves PLUVICTOâ„¢ as first targeted ... - Newswire
Sep 7, 2022 Health Canada approves PLUVICTOâ„¢ as first targeted radioligand therapy for progressive PSMA‑positive metastatic castration-resistant prostate cancer FrançaisSee details»
Advanced Accelerator Applications Receives US FDA Approval
Jan 26, 2018 First-in-class Therapy Demonstrated 79% Improvement in Progression Free Survival in NETTER-1 Phase 3 Study in Midgut NET Patients LUTATHERA® marks first...See details»
Novartis completes tender offer for Advanced Accelerator …
Basel, January 22, 2018 - Novartis AG (NYSE: NVS) today announced the successful completion of the tender offer by its subsidiary, Novartis Groupe France S.A., to purchase all of the …See details»
Advanced Accelerator Applications to Build Targeted Radioligand …
Jun 30, 2020 SAINT-GENIS-POUILLY, France, June 30, 2020 /PRNewswire/ -- Advanced Accelerator Applications S.A. (AAA), a Novartis company, today announced it has executed a …See details»
Health Canada approves PLUVICTOâ„¢ as first targeted ... - Novartis
Sep 7, 2022 For more information, please visit: https://www.adacap.com. Media contacts. Daphne Weatherby. Novartis Pharmaceuticals Communications + 1 514 633 7873. E-mail: …See details»
Radiopharmaceutical Lutathera® now reimbursed in Quebec for …
Oct 1, 2020 Lutathera is the first and only therapeutic radiopharmaceutical indicated in the treatment of GEP-NETs in Canada; Lutathera directly targets tumours by binding to cancer cell …See details»